Plain-English translation of NCT04180930 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are evaluating two different assessment tools used to diagnose and measure post-traumatic stress disorder (PTSD) in military service members and veterans. This study also explores whether certain blood markers or biological signals might help identify PTSD and improve how doctors diagnose and treat it. The goal is to make sure these assessment tools are reliable and accurate so that people with PTSD get better, faster care.
Current ways of assessing PTSD in military populations need to be tested more thoroughly to ensure they accurately measure PTSD symptoms and can guide better treatment decisions. Understanding biomarkers — physical signs in the blood — could help doctors identify PTSD earlier and develop more targeted treatments.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of four study groups and complete between two and seven research visits. During these visits, you will complete PTSD assessments (questionnaires or interviews), answer questions about your thinking and behavior, and may provide blood samples. Some participants will complete just one assessment visit, while others will return multiple times over 12 weeks to repeat the assessments and provide additional samples so researchers can see how consistent the measurements are.
AI-generated summary from trial data · Jun 17, 2026 · Not medical advice
United States